Unresectable, metastatic enteropancreatic neuroendocrine tumors
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB06791 | Lanreotide | A somatostatin analog used for the treatment of unresectable, well- or moderately-differentiated, locally advanced or metastatic gastroenteropancreatic neuroendocrine tumors and acromegaly. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB06791 | Lanreotide | Somatostatin receptor type 2 | target |
| DB06791 | Lanreotide | Somatostatin receptor type 5 | target |
| DB06791 | Lanreotide | Cytochrome P450 3A4 | enzyme |
| Drug | Drug Name | Phase | Status | Count |
|---|